MedTrace Logo

Assessment of the 90-day Mortality Risk Score After VATS Lobectomy

NCT04799509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2209

Last updated 2021-03-22

No results posted yet for this study

Summary

A five classes (A-E) aggregate risk score predicting 90-day mortality after video-assisted thoracoscopic lobectomy for lung cancer, including as independent factors male sex (3 points), carbon monoxide lung diffusion capacity \<60% (1 point) and operative time \>150 minutes (1 point), has been recently published. This study aims to assess the effectiveness and reliability of this risk model in a large, independent cohort of patients, in order to confirm its generalizability.

Conditions

Interventions

PROCEDURE

VATS lobectomy

VATS lobectomy

Sponsors & Collaborators

  • Università degli Studi dell'Insubria

    lead OTHER

Principal Investigators

  • Andrea Imperatori, MD · Università degli Studi dell'Insubria

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2018-11-27
Completion
2018-11-27

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04799509 on ClinicalTrials.gov